CONCURRENT GENOMIC DELETIONS IMPACT THE RESPONSE TO PARP INHIBITION IN PROSTATE CANCER

$1,320,615FY2022Defense Health AgencyDOD

Brigham & Womens Hospital Inc

Investigators

View source on USAspending →